Novartis Not to Plead Glivec Case

Triggering a fresh legal wrangle, Swiss drug major Novartis on Wednesday filed a writ petition with the Madras High Court contesting the Intellectual Property Appellate Board (IPAB)’s decision to let former Patent Controller General S Chandrasekaran hear its appeal for Glivec.
Economic Times